Targeted Immunotherapy for Regulatory T Cells 2307761
Underperformance and dysfunction of CD4+ regulatory T cells (Tregs) has been implicated in the pathogenesis of many autoimmune diseases. As such, multiple approaches toward Treg immunotherapy are being developed, most of which require ex vivo expansion and/or manipulation of Tregs, and in vivo strategies remain c...